Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant

Development and evaluation of sustained release losartan potassium matrix tablet using kollidon SR as release retardant

The present study was undertaken to develop sustained release (SR) matrix tablets of losartan potassium, an angiotensin-II antagonist for the treatment of hypertension. The tablets were prepared by direct compression method, along with Kollidon SR as release retardant polymer. The amount of losartan...

Full description

Bibliographic Details
Main Authors:	Shahid Sarwar, Mohammad Salim Hossain
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2012-12-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Losartana Comprimidos Kollidon SR. Losartan potassium Tablets
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502012000400005

Similar Items

The application of povidone in the preparation of modified release tablets
by: Kasperek Regina, et al.
Published: (2016-06-01)

Preparation, optimization and characterization of multiple unit microspheres containing kollidone SR
by: Marvin I Patel, et al.
Published: (2012-01-01)

Losartan potassium dissolution test for drug release evaluation in pharmaceutical capsules using HPLC and UV spectrophotometry
by: Rudy Bonfilio, et al.
Published: (2010-01-01)

Preparation and Characterization of a Novel Swellable and Floating Gastroretentive Drug Delivery System (<i>sf</i>GRDDS) for Enhanced Oral Bioavailability of Nilotinib
by: Hong-Liang Lin, et al.
Published: (2020-02-01)

Enhanced Dissolution of Sildenafil Citrate Using Solid Dispersion with Hydrophilic Polymers: Physicochemical Characterization and In Vivo Sexual Behavior Studies in Male Rats
by: Mohammed F. Aldawsari, et al.
Published: (2021-10-01)

Enhancing the dissolution rate of poorly soluble drug Febuxostat using spray dried amorphous solid dispersion technique
by: Vaishali Patel, et al.
Published: (2023-06-01)

Design and Evaluation of Losartan Potassium Effervescent Floating Matrix Tablets: In Vivo X-ray Imaging and Pharmacokinetic Studies in Albino Rabbits
by: Mohamed Rahamathulla, et al.
Published: (2021-10-01)

Pharmaceutical Development of Film-Coated Mini-Tablets with Losartan Potassium for Epidermolysis Bullosa
by: Valentinë Elezaj, et al.
Published: (2022-03-01)

Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation
by: Shazia Akram Ghumman, et al.
Published: (2023-08-01)

Use of hydrophilic and hydrophobic polymers for the development of controlled release tizanidine matrix tablets
by: Tariq Ali, et al.
Published: (2014-12-01)

Degradation of Losartan Potassium Highlighted by Correlated Studies of Photoluminescence, Infrared Absorption Spectroscopy and Dielectric Spectroscopy
by: Mirela Paraschiv, et al.
Published: (2022-11-01)

Preparation of Losartan Potassium Controlled Release Matrices and In-Vitro Investigation Using Rate Controlling Agents
by: Kamran Ahmad Khan, et al.
Published: (2022-01-01)

Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats
by: Mohammed Muqtader Ahmed, et al.
Published: (2022-05-01)

Losartan Potassium and Verapamil Hydrochloride Compound Transdermal Drug Delivery System: Formulation and Characterization
by: Yu-si Chen, et al.
Published: (2022-10-01)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
by: Zhenchao Niu, et al.
Published: (2022-04-01)

Formulation and Preparation of Losartan-Potassium-Loaded Controlled-Release Matrices Using Ethocel Grade 10 to Establish a Correlation between In Vitro and In Vivo Results
by: Kamran Ahmad Khan, et al.
Published: (2024-01-01)

Estudo "LOTHAR": avaliação de eficácia e tolerabilidade da combinação fixa de anlodipino e losartana no tratamento da hipertensão arterial primária The "LOTHAR" study: evaluation of efficacy and tolerability of the fixed combination of amlodipine and losartan in the treatment of essential hypertension
by: Osvaldo Kohlmann Jr, et al.
Published: (2006-01-01)

COMPARATIVE EVALUATION OF THE ANTIHYPERTENSIVE EFFECT OF PERINDOPRIL AND LOSARTAN POTASSIUM IN PATIENTS WITH ARTERIAL HYPERTENSION AND STENOTIC CORONARY ATHEROSCLEROSIS BEFORE REVASCULARIZATION: AN OPEN RANDOMIZED COMPARATIVE STUDY
by: O. A. Osipova, et al.
Published: (2016-01-01)

Optimization of a spectrofluorimetric method based on a central composite design for the determination of potassium losartan in pharmaceutical products
by: Fatma Demirkaya-Miloglu, et al.
Published: (2014-09-01)

Diferenças entre os Bloqueadores dos Receptores da Angiotensina (BRA) no Tratamento da Hipertensão Arterial
by: José Geraldo Mill
Published: (2022-06-01)

A statistical study on the development of micro particulate sustained drug delivery system for Losartan potassium by 32 factorial design approach
by: Gokul Khairnar, et al.
Published: (2017-06-01)

Determination of Losartan and Losartan Carboxylic acid in Human Plasma by New HPLC Method with Fluorescence Detection for Pharmacokinetics Studies
by: Ahmed Abbas Hussein
Published: (2014-12-01)

Determination of clemastine hydrogen fumarate, desloratadine, losartan potassium and moxepril HCl through binary complex formation with eosin
by: Soad S. Abd El-Hay, et al.
Published: (2016-09-01)

Optimized and Validated RP-UPLC Method for the Determination of Losartan Potassium and Chlorthalidone in Pharmaceutical Formulations
by: Tadiboyina Sirisha, et al.
Published: (2015-03-01)

FORMULATION OF CHLORPHENIRAMINE MALEATE TABLETS USING CO-PROCESSED EXCIPIENT AS A FILLER AND BINDER
by: Yandi Syukri, et al.
Published: (2019-05-01)

Synthesis and Characterization of Nanoporous Carbon Carriers for Losartan Potassium Delivery
by: Aleksander Ejsmont, et al.
Published: (2021-11-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Análise do perfil terapêutico, clínico e epidemiológico de pacientes com hipertensão atendidos no serviço de cardiologia de um hospital terciário
by: Daniel Henrique Barbosa, et al.
Published: (2018-09-01)

Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study
by: Lee Hae-Young, et al.
Published: (2011-10-01)

Applicability of XRF technique to Rb-Sr chemical dating of K-bearing minerals
by: O. A. Andreiev
Published: (2014-12-01)

Functional Vascular Study in Hypertensive Subjects with Type 2 Diabetes Using Losartan or Amlodipine
by: Cesar Romaro Pozzobon, et al.
Published: (2014-07-01)

Application of Solid Dispersion Technology to Obtain a Model of Injectable Dosage Form of Indolocarbazole Derivative
by: A. P. Kolpaksidi, et al.
Published: (2022-11-01)

The Qi-Bang-Yi-Shen formula ameliorates renal dysfunction and fibrosis in rats with diabetic kidney disease <em>via</em> regulating PI3K/AKT, ERK and PPARγ signaling pathways
by: Zhi Wang, et al.
Published: (2023-03-01)

Losartan and QT Dispersion in Hypertensive Patients on Maintenance Hemodialysis
by: Alparslan Ersoy, et al.
Published: (2014-12-01)

Validation of a UV spectrophotometric method to quantify losartan potassium in tablets from the dissolution test at pH 1.2, 4.5 and 6.8
by: Antonella S. Araujo-Fernandez, et al.
Published: (2022-03-01)

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
by: Galina Anatol'evna Baryshnikova, et al.
Published: (2009-03-01)

Angiotensin receptor blockers in nephroprotection at patients with diabetes mellitus: focus on losartan
by: Ol'ga Konstantinovna Vikulova, et al.
Published: (2009-09-01)

Comparison of Anti Hypertensive Effect of Fixed Dose Enalapril and Losartan in Essential Hypertension
by: Khurram Mansoor
Published: (2009-06-01)

Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
by: EDNA GOMEZ ORTIZ, et al.
Published: (2014-01-01)

A randomised clinical trial study assessing the efficacy of 5% losartan potassium loaded in ethosomal gel to treat human keloids: a trial protocol
by: Yuni Eka Anggraini, et al.
Published: (2024-01-01)